Results 31 to 40 of about 276,902 (250)

Editorial : experimental models of asthma [PDF]

open access: yes, 2008
Since 2002, a workshop entitled “Asthma in animal models” has been held once a year in Hannover, Germany. It is organized by the Fraunhofer Institute of Toxicology and Experimental Medicine in collaboration with the collaborative research centre ...
Thomas Tschernig   +8 more
core   +1 more source

Eosinophilic bronchitis without asthma [PDF]

open access: yes, 2008
Background: Eosinophilic bronchitis without asthma causes chronic coughs without the physiologic features of asthma. The aim of this study was to review the clinical features, pathogenesis, diagnosis, treatment and prognosis of this condition ...
Gönlügür, Tanseli, Gönlügür, Uğur
core   +2 more sources

Fasting impairs type 2 helper T cell infiltration in the lung of an eosinophilic asthma mouse model

open access: yesFEBS Open Bio, 2021
Eosinophilic asthma is a form of bronchial asthma that is caused by the pulmonary infiltration of eosinophils and accounts for approximately half of the patients with severe asthma.
Yusuke Suzuki   +7 more
doaj   +1 more source

Utility of serum periostin in combination with exhaled nitric oxide in the management of asthma

open access: yesAllergology International, 2017
Type-2/eosinophilic inflammation plays a pivotal role in asthma. The identification of severe type-2/eosinophilic asthma is important for improving the management of patients with asthma.
Tadao Nagasaki   +19 more
doaj   +1 more source

Asthma control and sputum eosinophils in adult patients: a cross-sectional study in southern Brazil

open access: yesScientific Reports, 2023
Asthma control and health related quality of life are an important goal of asthma management, but their association with sputum eosinophilic inflammation has been less firmly established.
Vanessa Albano Barcellos   +3 more
doaj   +1 more source

Severe eosinophilic asthma and aspirin-exacerbated respiratory disease associated to eosinophilic gastroenteritis treated with mepolizumab: a case report [PDF]

open access: yes, 2020
Background: Mepolizumab (MEP) is the first anti Interleukin (IL)-5 add-on therapy approved for the treatment of severe refractory eosinophilic asthma.
C. Di Mario   +11 more
core   +3 more sources

Prevalence of eosinophilic, atopic, and overlap phenotypes among patients with severe asthma in Saudi Arabia: a cross-sectional study

open access: yesBMC Pulmonary Medicine, 2022
Background Eosinophilia is a significant factor in asthma severity; however, the prevalence of severe eosinophilic asthma in Saudi Arabia is largely unknown.
Hamdan Al-Jahdali   +6 more
doaj   +1 more source

Plasma Metabolites and Gut Microbiota Are Associated With T cell Imbalance in BALB/c Model of Eosinophilic Asthma

open access: yesFrontiers in Pharmacology, 2022
The pathogenesis of allergic asthma is complex, it is usually caused by immune system imbalance. Th1, Th2, regulatory T cells (Treg) and T helper 17 (Th17) cells have an important role in the pathogenesis of eosinophilic asthma.
Yumei Zhou   +4 more
doaj   +1 more source

The cough variant asthma [PDF]

open access: yesТерапевтический архив, 2020
Cough variant asthma (CVA) was first described by W. Corrao. CVA was described as the isolated chronic cough as the only presenting symptom responsive to bronchodilator therapy.This phenotype of asthma is present with airway hyperresponsiveness ...
M. O. Uryasjev   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy